Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
CME information and select publications here (researchtopractice.com/InsideTheIssue2025/CELM…).